Global offering of DBV Technologies ordinary shares
1 minutes ago - GlobeNewsWire via Dow Jones News
Global offering of DBV Technologies ordinary shares Over-allotment option exercised in full BAGNEUX, France, Oct. 23, 2014 (GLOBE NEWSWIRE) -- DBV Technologies (Euronext: DBV - ISIN: FR0010417345), a clinical-stage specialty biopharmaceutical company announced today that the underwriters in its recently announced global offering have exercised in full their options to purchase an additional 401,045 ordinary shares in the global offering, of which 320,836 ordinary shares in the form o...